PRIMARY GRAFT DYSFUNCTION

Clinical trials for PRIMARY GRAFT DYSFUNCTION explained in plain language.

Never miss a new study

Get alerted when new PRIMARY GRAFT DYSFUNCTION trials appear

Sign up with your email to follow new studies for PRIMARY GRAFT DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Repurposed drug could save transplanted lungs

Disease control Recruiting now

This study is testing if a drug called Maraviroc can prevent a dangerous complication called primary graft dysfunction (PGD) after a lung transplant. PGD is a major cause of early death and has no approved treatment. About 120 adult lung transplant patients at high risk for PGD w…

Matched conditions: PRIMARY GRAFT DYSFUNCTION

Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

PRIMARY GRAFT DYSFUNCTION

Get alerted when new PRIMARY GRAFT DYSFUNCTION trials appear

Repurposed drug could save transplanted lungs